Stereotaxis says the acquisition strengthens its position as “a leading platform for the full spectrum of endovascular procedures.” The post Stereotaxis to acquire Robocath for up to $45M appeared first on The Robot Report.
Stereotaxis says the acquisition strengthens its position as “a leading platform for the full spectrum of endovascular procedures.” The post Stereotaxis to acquire Robocath for up to $45M appeared first on The Robot Report.